Open access · US-GOV via ClinicalTrials.gov Clinical trial

Therapeutic Fasting and Immune Aging: A Pilot Study of Tolerance

Authors not listed

Centre Hospitalier Universitaire de Saint Etienne · 2025

Cellular senescence Chronic inflammation Intermittent fasting Human Randomized controlled trial

Abstract

Immunosenescence is the age-related decline of the immune system, involving a state of chronic inflammation and a decrease in the diversity/adaptability of the lymphocyte repertoire. The consequences of immunosenescence are multiple, including increased susceptibility to infections and poorer vaccine responses.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-29 MST

Cite this

APA

Anonymous. (2025). Therapeutic Fasting and Immune Aging: A Pilot Study of Tolerance. <em>Centre Hospitalier Universitaire de Saint Etienne</em>. https://clinicaltrials.gov/study/NCT05857241

Vancouver

Anonymous. Therapeutic Fasting and Immune Aging: A Pilot Study of Tolerance. Centre Hospitalier Universitaire de Saint Etienne. 2025.

BibTeX

@misc{anon2025Therap, title = {Therapeutic Fasting and Immune Aging: A Pilot Study of Tolerance}, author = {Anonymous}, journal = {Centre Hospitalier Universitaire de Saint Etienne}, year = {2025}, }